117 related articles for article (PubMed ID: 36126752)
21. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
22. Stability-indicating HPLC-PDA assay for simultaneous determination of paracetamol, thiamine and pyridoxal phosphate in tablet formulations.
Ali A; Athar MM; Ahmed M; Nadeem K; Murtaza G; Farooq U; Salman M
Acta Pharm; 2019 Jun; 69(2):249-259. PubMed ID: 31259722
[TBL] [Abstract][Full Text] [Related]
23. Validation of a stability-indicating RP-HPLC method for the determination of entecavir in tablet dosage form.
Dalmora SL; Sangoi Mda S; Nogueira DR; da Silva LM
J AOAC Int; 2010; 93(2):523-30. PubMed ID: 20480899
[TBL] [Abstract][Full Text] [Related]
24. Stability Indicating RP-HPLC-DAD method for simultaneous estimation of tadalafil and macitentan in synthetic mixture for treatment of pulmonary arterial hypertension.
Gol D; Vyas A; Visana N; Patel A; Shah S; Sheth D; Dholakia S
Ann Pharm Fr; 2024 May; 82(3):464-472. PubMed ID: 37866638
[TBL] [Abstract][Full Text] [Related]
25. Validated stability-indicating HPLC-DAD method for determination of the recently approved hepatitis C antiviral agent daclatasvir.
Baker MM; El-Kafrawy DS; Mahrous MS; Belal TS
Ann Pharm Fr; 2017 May; 75(3):176-184. PubMed ID: 28187879
[TBL] [Abstract][Full Text] [Related]
26. Developing and validation of impurity and the simultaneous quantity determination methods for tablet forms containing Ciprofloxacin HCl and Ornidazole.
Tunca AK; Karakaya D; Bulbul S
Pak J Pharm Sci; 2020 May; 33(3):1105-1114. PubMed ID: 33191235
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of an analytical method for metformin hydrochloride and its related compound (1-cyanoguanidine) in tablet formulations by HPLC-UV.
Al-Rimawi F
Talanta; 2009 Oct; 79(5):1368-71. PubMed ID: 19635372
[TBL] [Abstract][Full Text] [Related]
28. Stability-indicating assay, dissolution, and content uniformity of sodium levothyroxine in tablets.
Richheimer SL; Amer TM
J Pharm Sci; 1983 Nov; 72(11):1349-51. PubMed ID: 6644603
[TBL] [Abstract][Full Text] [Related]
29. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.
Joshi SJ; Karbhari PA; Bhoir SI; Bindu KS; Das C
J Pharm Biomed Anal; 2010 Jul; 52(3):362-71. PubMed ID: 19926421
[TBL] [Abstract][Full Text] [Related]
30. Method Development and Validation of a Stability-Indicating RP-HPLC Method for the Quantitative Analysis of Dronedarone Hydrochloride in Pharmaceutical Tablets.
Dabhi B; Jadeja Y; Patel M; Jebaliya H; Karia D; Shah A
Sci Pharm; 2013; 81(1):115-22. PubMed ID: 23641332
[TBL] [Abstract][Full Text] [Related]
31. High performance liquid chromatographic assay of amlodipine, valsartan and hydrochlorothiazide simultaneously and its application to pharmaceuticals, urine and plasma analysis.
Shaikh JSA; Raut S; Abdul A; Pathan MAAK
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Oct; 1155():122295. PubMed ID: 32771968
[TBL] [Abstract][Full Text] [Related]
32. Validation and application of a new reversed phase HPLC method for in vitro dissolution studies of rabeprazole sodium in delayed-release tablets.
Nawaz MS
J Anal Methods Chem; 2013; 2013():976034. PubMed ID: 24062966
[TBL] [Abstract][Full Text] [Related]
33. A stability-indicating HPLC method for simultaneous determination of morphine and naltrexone.
Jafari-Nodoushan M; Barzin J; Mobedi H
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1011():163-70. PubMed ID: 26773883
[TBL] [Abstract][Full Text] [Related]
34. Liquid chromatographic and spectrofluorimetric assays of empagliflozin: Applied to degradation kinetic study and content uniformity testing.
Abdel-Ghany MF; Ayad MF; Tadros MM
Luminescence; 2018 Aug; 33(5):919-932. PubMed ID: 29737023
[TBL] [Abstract][Full Text] [Related]
35. Development of stability indicating reversed-phase high-performance liquid chromatography method for determination of elobixibat in pure form and laboratory prepared tablets: Application to dissolution study.
Elagamy SH; Mansour FR; Elbastawissy ABB; El-Malla SF
J Sep Sci; 2022 Sep; 45(18):3529-3541. PubMed ID: 35894696
[TBL] [Abstract][Full Text] [Related]
36. Stability-indicating RP-HPLC method for the quantitative analysis of perindopril erbumine in tablet dosage form.
Dugga HH; Peraman R; Nayakanti D
J Chromatogr Sci; 2014 Apr; 52(4):315-20. PubMed ID: 23690066
[TBL] [Abstract][Full Text] [Related]
37. Stability-indicating liquid chromatography method development for assay and impurity profiling of amitriptyline hydrochloride in tablet dosage form and forced degradation study.
Boppy NVVDP; Haridasyam SB; Vadagam N; Pasham M; Venkatanarayana M; Begum B
Biomed Chromatogr; 2022 Oct; 36(10):e5436. PubMed ID: 35766584
[TBL] [Abstract][Full Text] [Related]
38. A validated stability-indicating reversed-phase-HPLC method for dipyridamole in the presence of degradation products and its process-related impurities in pharmaceutical dosage forms.
Mallavarapu R; Katari NK; Dongala T; Rekulapally VK; Marisetti VM; Vyas G
Biomed Chromatogr; 2022 Jan; 36(1):e5247. PubMed ID: 34541698
[TBL] [Abstract][Full Text] [Related]
39. An eco-friendly HPLC-UV method for the determination of risedronate in its bulk and tablet dosage form with application to content uniformity, dissolution and stability testing.
Moustapha ME; Kamal M; Elgamal RM
Saudi Pharm J; 2020 Nov; 28(11):1301-1308. PubMed ID: 33250639
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of a reversed-phase ultra-performance liquid chromatographic method for assay of lacidipine and related substances.
Mohan A; Patel HB; Saravanan D
J AOAC Int; 2011; 94(6):1800-6. PubMed ID: 22320087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
